Equity Overview
Price & Market Data
Price: $11.69
Daily Change: +$0.31 / 2.65%
Daily Range: $11.33 - $12.00
Market Cap: $139,631,744
Daily Volume: 55,783
Performance Metrics
1 Week: -5.27%
1 Month: -5.04%
3 Months: 17.25%
6 Months: -6.85%
1 Year: 18.20%
YTD: 0.52%
Company Details
Employees: 140
Sector: Health technology
Industry: Medical specialties
Country:
Details
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.